0001171843-15-000644.txt : 20150205
0001171843-15-000644.hdr.sgml : 20150205
20150205170433
ACCESSION NUMBER: 0001171843-15-000644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150203
FILED AS OF DATE: 20150205
DATE AS OF CHANGE: 20150205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERWOOD CHARLES H
CENTRAL INDEX KEY: 0001244298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 15580957
4
1
gff4_sherwood020515.xml
OWNERSHIP DOCUMENT
X0306
4
2015-02-03
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001244298
SHERWOOD CHARLES H
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
1
0
0
President and CEO
Common Stock
2015-02-03
4
A
0
13500
0
A
191455
D
Common Stock
2015-02-04
4
A
0
50000
8.71
A
241455
D
Stock Option (Right to Buy)
39.69
2015-02-03
4
A
0
34200
0
A
2025-02-03
Common Stock
13700
34200
D
Stock Option (Right to Buy)
32.02
2015-02-03
4
A
0
16600
0
A
2024-01-27
Common Stock
16600
16600
D
Stock Option (Right to Buy)
8.71
2015-02-04
4
M
0
50000
0
D
2015-02-10
Common Stock
50000
0
D
Restricted stock awards vest in four equal annual installments beginning February 3, 2016.
Exercise of stock options granted on February 10, 2005 with an expiration date of February 10, 2015.
The stock options vest in four equal annual installments beginning February 3, 2016.
The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2014, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 5 and 6.
On February 3, 2015, the Compensation Committee modified the performance measures under the Performance Grant and determined that under the modified performance measures 100% of the performance grant had been earned, subject to time-based vesting. Please also see notes 4 and 6.
The stock options vest in four equal installments on the following dates: February 3, 2015, January 1, 2016, January 1, 2017 and January 1, 2018.
/s/ Charles H. Sherwood, Ph. D.
2015-02-05